Report overview
RNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.
This report aims to provide a comprehensive presentation of the global market for RNAi Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technology. This report contains market size and forecasts of RNAi Technology in global, including the following market information:
Global RNAi Technology Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global RNAi Technology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cancer Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNAi Technology include Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Quark Pharmaceuticals, Inc., Arbutus Biopharma, Benitec Biopharma, Calando and Silence Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNAi Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNAi Technology Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global RNAi Technology Market Segment Percentages, by Type, 2022 (%)
Cancer
Liver Disorders
Respiratory Disorders
Neurological Disorders
Autoimmune Disorders
Others
Global RNAi Technology Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global RNAi Technology Market Segment Percentages, by Application, 2022 (%)
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
Global RNAi Technology Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global RNAi Technology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNAi Technology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies RNAi Technology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma
Calando
Silence Therapeutics
Gotham Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNAi Technology, market overview.
Chapter 2: Global RNAi Technology market size in revenue.
Chapter 3: Detailed analysis of RNAi Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNAi Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
